These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9834209)

  • 21. Two brothers with mild congenital erythropoietic porphyria due to a novel genotype.
    Berry AA; Desnick RJ; Astrin KH; Shabbeer J; Lucky AW; Lim HW
    Arch Dermatol; 2005 Dec; 141(12):1575-9. PubMed ID: 16365260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic bone marrow transplantation in a 7-year-old girl with congenital erythropoietic porphyria: a treatment dilemma.
    Taibjee SM; Stevenson OE; Abdullah A; Tan CY; Darbyshire P; Moss C; Goodyear H; Heagerty A; Whatley S; Badminton MN
    Br J Dermatol; 2007 Mar; 156(3):567-71. PubMed ID: 17300251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic analysis of the mutations of the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria.
    Fontanellas A; Bensidhoum M; Enriquez de Salamanca R; Moruno Tirado A; de Verneuil H; Ged C
    Eur J Hum Genet; 1996; 4(5):274-82. PubMed ID: 8946173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital erythropoietic porphyria.
    Fritsch C; Bolsen K; Ruzicka T; Goerz G
    J Am Acad Dermatol; 1997 Apr; 36(4):594-610. PubMed ID: 9092747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of the genotype-phenotype relationship in four cases of congenital erythropoietic porphyria.
    To-Figueras J; Badenas C; Mascaró JM; Madrigal I; Merino A; Bastida P; Lecha M; Herrero C
    Blood Cells Mol Dis; 2007; 38(3):242-6. PubMed ID: 17270473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel point mutation in the uroporphyrinogen III synthase gene causes congenital erythropoietic porphyria of a Japanese family.
    Takamura N; Hombrados I; Tanigawa K; Namba H; Nagayama Y; de Verneuil H; Yamashita S
    Am J Med Genet; 1997 Jun; 70(3):299-302. PubMed ID: 9188670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A management algorithm for congenital erythropoietic porphyria derived from a study of 29 cases.
    Katugampola RP; Anstey AV; Finlay AY; Whatley S; Woolf J; Mason N; Deybach JC; Puy H; Ged C; de Verneuil H; Hanneken S; Minder E; Schneider-Yin X; Badminton MN
    Br J Dermatol; 2012 Oct; 167(4):888-900. PubMed ID: 22804244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Congenital erythropoietic porphyria: a novel uroporphyrinogen III synthase branchpoint mutation reveals underlying wild-type alternatively spliced transcripts.
    Bishop DF; Schneider-Yin X; Clavero S; Yoo HW; Minder EI; Desnick RJ
    Blood; 2010 Feb; 115(5):1062-9. PubMed ID: 19965637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of two new mutations in congenital erythropoietic porphyria.
    Bensidhoum M; Ged C; Hombrados I; Moreau-Gaudry F; Hift RS; Meissner P; Sturrock ED; de Verneuil H
    Eur J Hum Genet; 1995; 3(2):102-7. PubMed ID: 7552139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational analysis of uroporphyrinogen III cosynthase gene in Iranian families with congenital erythropoietic porphyria.
    Moghbeli M; Maleknejad M; Arabi A; Abbaszadegan MR
    Mol Biol Rep; 2012 Jun; 39(6):6731-5. PubMed ID: 22350154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in understanding the pathogenesis of congenital erythropoietic porphyria.
    Di Pierro E; Brancaleoni V; Granata F
    Br J Haematol; 2016 May; 173(3):365-79. PubMed ID: 26969896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lentivirus-mediated gene transfer of uroporphyrinogen III synthase fully corrects the porphyric phenotype in human cells.
    Géronimi F; Richard E; Lamrissi-Garcia I; Lalanne M; Ged C; Redonnet-Vernhet I; Moreau-Gaudry F; de Verneuil H
    J Mol Med (Berl); 2003 May; 81(5):310-20. PubMed ID: 12721665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction of deficient CD34+ cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria.
    Mazurier F; Géronimi F; Lamrissi-Garcia I; Morel C; Richard E; Ged C; Fontanellas A; Moreau-Gaudry F; Morey M; de Verneuil H
    Mol Ther; 2001 Mar; 3(3):411-7. PubMed ID: 11273784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction of congenital erythropoietic porphyria by bone marrow transplantation.
    Thomas C; Ged C; Nordmann Y; de Verneuil H; Pellier I; Fischer A; Blanche S
    J Pediatr; 1996 Sep; 129(3):453-6. PubMed ID: 8804339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Congenital erythropoietic porphyria: identification and expression of exonic mutations in the uroporphyrinogen III synthase gene.
    Warner CA; Yoo HW; Roberts AG; Desnick RJ
    J Clin Invest; 1992 Feb; 89(2):693-700. PubMed ID: 1737856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Congenital erythropoietic porphyria].
    Tanigawa K; Takamura N; Yamashita S
    Nihon Rinsho; 1995 Jun; 53(6):1422-6. PubMed ID: 7616657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological, enzymatic and biochemical studies of uroporphyrinogen III-synthase deficiency in 20 patients with congenital erythropoietic porphyria.
    Freesemann AG; Gross U; Bensidhoum M; de Verneuil H; Doss MO
    Eur J Biochem; 1998 Oct; 257(1):149-53. PubMed ID: 9799113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone Marrow Transplantation in Congenital Erythropoietic Porphyria: Sustained Efficacy but Unexpected Liver Dysfunction.
    Besnard C; Schmitt C; Galmiche-Rolland L; Debray D; Fabre M; Molina T; Gouya L; Ged C; Castelle M; Cavazzana M; Magrin E; Neven B; Moshous D; Blanche S; Frémond ML
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):704-711. PubMed ID: 31843562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic correction of congenital erythropoietic porphyria by retrovirus-mediated gene transfer into Epstein-Barr virus-transformed B-cell lines.
    Moreau-Gaudry F; Mazurier F; Bensidhoum M; Ged C; de Verneuil H
    Blood; 1995 Mar; 85(6):1449-53. PubMed ID: 7888667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition.
    Blouin JM; Bernardo-Seisdedos G; Sasso E; Esteve J; Ged C; Lalanne M; Sanz-Parra A; Urquiza P; de Verneuil H; Millet O; Richard E
    Hum Mol Genet; 2017 Apr; 26(8):1565-1576. PubMed ID: 28334762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.